Press release – 12.07.2017

Theraclion’s Echopulse® Covered by French National Health Insurance for the Treatment of Breast Fibroadenomas


The treatment of breast fibroadenomas with high intensity focused ultrasound (HIFU) is covered within the Forfait Innovation process


THERACLION today announced the publication in the Official Gazette of the order relating to the reimbursement for its medical device Echopulse® for the treatment of breast adenofibromas, pursuant to Article L. 165-1-1 of the Code of Social Security:


Read the press release

Print Friendly